The Clorox Company (NYSE:CLX) Weekly Ratings as of Jan 12, 2019

The Clorox Company (NYSE:CLX) Corporate Logo
Big Money Sentiment decreased to 0.86 in 2018 Q3. It has change of 0.14, from 2018Q2’s 1. The ratio dived due to The Clorox Company positioning: 39 sold and 270 reduced. 84 funds took positions and 181 increased positions. Investors holded 96.82 million in 2018Q2 but now own 95.79 million shares or 1.06% less.
Carlton Hofferkamp Jenks Wealth Mngmt Ltd Liability Corp holds 0.39% or 4,220 shs. Hartford Investment Mgmt Com stated it has 14,331 shs. 42,291 were accumulated by Nuance Limited Liability. Hamel Associates Inc reported 1,500 shs. Gillespie Robinson And Grimm invested in 0.03% or 1,705 shs. Pictet Asset Ltd reported 78,912 shs stake. Brookstone Management owns 0.04% invested in The Clorox Company (NYSE:CLX) for 3,373 shs. Scout Invs owns 174,697 shs. Freestone Capital Ltd Llc holds 0% or 2,074 shs in its capital. Great West Life Assurance Can invested in 0.04% or 112,033 shs. U S Glob Invsts holds 1,781 shs. Cedar Rock has 2.88M shs for 10.67% of their capital. Pub Employees Retirement Of Ohio owns 62,972 shs or 0.05% of their US capital. 1St Source Bank & Trust invested in 1,829 shs or 0.02% of the stock. Opus Inv Management accumulated 5,000 shs.

The Clorox Company registered $55.11 million net activity with 0 buys and 14 insider sales since August 13, 2018. 3,694 shs were sold by Baker Jeff, worth $600,487 on Friday, December 7. Shares for $56,657 were sold by Rendle Linda J on Thursday, September 6. On Tuesday, December 4 $4.27 million worth of The Clorox Company (NYSE:CLX) was sold by Willoughby Dawn C. Barral Diego J had sold 12,880 shs worth $2.03M on Tuesday, November 6. $25.13 million worth of The Clorox Company (NYSE:CLX) shs were sold by Dorer Benno O. On Friday, August 31 $1.86M worth of The Clorox Company (NYSE:CLX) was sold by STEIN LAURA.

The Clorox Company (NYSE:CLX) Ratings Coverage

In total 9 analysts cover Clorox (NYSE:CLX). “Buy” rating has 2, “Sell” are 3, while 4 are “Hold”. (NYSE:CLX) has 22% bullish analysts. 12 are the (NYSE:CLX)’s ratings reports on Jan 12, 2019 according to StockzIntelligence Inc. In Friday, November 2 report BMO Capital Markets maintained it with “Outperform” rating and $165 target. The company rating was downgraded by Deutsche Bank on Wednesday, October 10. In Tuesday, September 25 report Argus Research upgraded it to “Buy” rating and $175 target. The stock rating was maintained by Bank of America with “Neutral” on Monday, July 16. The company rating was maintained by Citigroup on Tuesday, November 20. On Wednesday, October 17 Wells Fargo maintained The Clorox Company (NYSE:CLX) with “Market Perform” rating. On Thursday, November 1 the rating was maintained by Deutsche Bank with “Sell”. On Friday, November 2 the company was maintained by Citigroup. On Wednesday, December 12 the rating was maintained by Wells Fargo with “Market Perform”. In Wednesday, July 18 report Goldman Sachs downgraded it to “Sell” rating and $112 target. Listed here are The Clorox Company (NYSE:CLX) PTs and latest ratings.

12/12/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $145 New Target: $160 Maintain
20/11/2018 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $153 New Target: $169 Maintain
02/11/2018 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $149 New Target: $153 Maintain
02/11/2018 Broker: BMO Capital Markets Old Rating: Outperform New Rating: Outperform Old Target: $153 New Target: $165 Maintain
01/11/2018 Broker: Deutsche Bank Old Rating: Sell New Rating: Sell Old Target: $123 New Target: $124 Maintain
17/10/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $135 New Target: $145 Maintain
10/10/2018 Broker: Deutsche Bank Old Rating: Hold New Rating: Sell Downgrade
25/09/2018 Broker: Argus Research Old Rating: Hold New Rating: Buy New Target: $175 Upgrade
20/09/2018 Broker: Atlantic Securities Rating: Neutral New Target: $151 Initiates Coverage On
19/07/2018 Broker: UBS Rating: Sell New Target: $110 Initiates Coverage On

CLX touched $153.35 during the last trading session after $0.24 change.The Clorox Company has 1.16 million shares volume, 5.76% up from normal. CLX is uptrending and has moved 12.45% since January 12, 2018. CLX outperformed by 12.45% the S&P500.

The Clorox Company manufactures and markets consumer and professional products worldwide.The firm is worth $19.58 billion. It operates through four divisions: Cleaning, Household, Lifestyle, and International.The P/E ratio is 23.89. The firm offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighters and color boosters; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brands.

Another two news for The Clorox Company (NYSE:CLX) were recently released by: Seekingalpha.com on December 10, 2018 with title “Clorox shuffles leaders as COO resigns post – Seeking Alpha”. The other Bizjournals.com‘s article was titled “Clorox’s Burt’s Bees cuts deal with P&G to build buzz over toothpaste – San Francisco Business Times” and released on December 31, 2018.

The Clorox Company (NYSE:CLX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.